Selected A-share Announcements | Trina Solar Co., Ltd. (688599.SH) Signs Memorandum of Cooperation on 5GWh Energy Storage with its Holding Subsidiary

Focus today 1. Trina Solar Co., Ltd.: Signs memorandum of cooperation with Pacific Green for 5GWh grid-level battery energy storage system Trina Solar Co., Ltd. announced that its subsidiary, Tianhe Energy, has signed a memorandum of cooperation with Pacific Green to work together on supplying a 5GWh grid-level battery energy storage system from 2026 to 2028. Pacific Green and Tianhe Energy plan to establish a strategic partnership for supplying battery energy storage systems from 2026 to 2028, with a total capacity of 5GWh. Tianhe Energy will provide its advanced grid-level battery system, which integrates industry-leading technology and has outstanding advantages in terms of safety, efficiency, and lifespan; Pacific Green will be responsible for the development and project delivery at multiple project locations in Australia and other international markets. Once all projects are completed, they will have the capacity to store and transmit up to 5 billion kWh of energy to the grid. 2. Ningbo TIP Rubber Technology: Completion of share transfer under agreement with controlling shareholder and acting in concert with ZongHao XinYing Ningbo TIP Rubber Technology announced that the share transfer agreement signed with ZongHao XinYing by the company's controlling shareholders, Tianpu Holdings, Tianxin Trading, You Jianyi, has been completed, with a total of 25.14 million shares transferred, accounting for 18.75% of the total shares of the company. After this transfer agreement, there has been no change in the controlling shareholder or actual controller of the company, with Tianpu Holdings remaining the controlling shareholder and You Jianyi remaining the actual controller. There is uncertainty regarding the change in control, as well as uncertainty about whether the relevant approval process can be completed and the timing of such completion. In addition, there is a risk that the company may not meet the listing requirements for share distribution, and if there is any insider trading, market manipulation, or other abnormal trading activities in this transaction, there may be a risk of termination. 3. Sichuan Biokin Pharmaceutical: Innovative biopharmaceutical T-Bren (HER2ADC) included in list of breakthrough therapies Sichuan Biokin Pharmaceutical announced that its independently developed innovative biopharmaceutical T-Bren (HER2ADC) has been included in the list of breakthrough therapies for the treatment of HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma patients who have failed first-line anti-HER2 therapy and first-line standard chemotherapy regimens. T-Bren has the potential to be the best-in-class among similar products and has demonstrated significant anti-tumor efficacy in clinical trials. Currently, T-Bren is undergoing 14 clinical trials both domestically and internationally, covering multiple indications for HER2-positive tumors. 4. Foxconn Industrial Internet: Repurchase of 0.04% of company shares as of October 31, with a repurchase amount of 147 million yuan Foxconn Industrial Internet announced that as of October 31, 2025, the company has repurchased a total of 7.6974 million shares through the Shanghai Stock Exchange trading system through centralized competitive trading, accounting for 0.04% of the total share capital of the company. The repurchase price ranged from 18.4 yuan/share to 19.84 yuan/share, with a total repurchase amount of 147 million yuan (excluding transaction fees such as brokerage fees and transfer fees). 5. Fuyao Glass Industry Group: Change of legal representative from Cao Dewang to his son Cao Hui Fuyao Glass Industry Group announced that the company has completed the registration procedures for the change of legal representative and has obtained a new Business License issued by the Market Supervision Administration of Fuzhou. After this registration change, the legal representative listed on the business license has been changed from Cao Dewang to Cao Hui. Apart from this matter, there have been no changes to the other items listed on the Business License. 6. Haichuang Pharmaceutical: Completion of enrollment of first batch of participants in Phase II clinical trial of metabolic-related fatty liver disease drug HP515, currently no similar target products approved for market Haichuang Pharmaceutical announced that the Phase II clinical trial of HP515, a drug for the treatment of metabolic-related fatty liver disease (MASH, formerly known as non-alcoholic fatty liver disease (NASH)), has recently completed the enrollment of the first batch of participants. HP515 tablets are a orally selective THR- agonist developed by the company, and there are currently no similar target products approved for market in China. The study aims to evaluate the efficacy, safety, pharmacokinetics, and pharmacology of HP515 in MASH subjects. The company is conducting research on the use of HP515 in combination with GLP-1R agonists for obesity and has presented relevant preclinical research data at international conferences. The completion of this study will not have a major impact on the company's recent operating performance, but pharmaceutical products have the characteristics of high technology, high risk, and high added value, and there is uncertainty regarding the progress and results of clinical trials, as well as the future market competition situation. 7. Zhejiang Truelove Vogue: Planning for changes in control; stock trading suspended Zhejiang Truelove Vogue announced that on November 4, 2025, the company received a notice from its controlling shareholder, Truelove Group, stating that they are planning a transfer of control of the company, which may lead to a change in the company's controlling shareholder and actual controller. The matter is still under negotiation, and there is significant uncertainty at present. In order to protect the interests of investors, the company's stock will be suspended from trading starting from November 5, 2025, for an expected period of no more than 2 trading days. During the suspension period, the company will fulfill its disclosure obligations based on the progress of the negotiations. 8. Vanfund Urban Investment & Development: Abnormal stock price fluctuations mainly due to market's excessive interpretation and speculation on rumors of a change in company's control Vanfund Urban Investment & Development issued an announcement on abnormal stock trading fluctuations, stating that the company has observed recent market rumors that have led to an excessive interpretation and speculation on the possibility of a change in the company's control. On October 10, 2025, the company's major shareholder, Wanfangyuan, received an "Execution Ruling," where the 9,086 million shares held by Wanfangyuan in the company were twice put up for auction, with no successful bids. Jiutai Rural Commercial Bank applied to Changchun Intermediate People's Court to receive property as compensation for debts at the reserve price set for the second auction of the 9,086 million shares held by Wanfangyuan in the company. After the completion of the transfer of shares, Wanfangyuan will lose its status as the company's largest shareholder and will no longer hold any shares of the company, posing a risk of a change in the controlling shareholder and actual controller of the company, or a situation where there is no actual controller. 9. Henan Thinker Automatic Equipment: Dismissal of Zhao Jianzhou from the position of Deputy General Manager; Zhao Jianzhou placed under detention and investigation Henan Thinker Automatic Equipment announced that on November 4, 2025, the company held a board meeting to consider and approve the resolution on the dismissal of Zhao Jianzhou from the position of Deputy General Manager. It was unanimously agreed to dismiss Zhao Jianzhou from the position of Deputy General Manager, but he will continue to hold a position as a director of the company and will also serve as the Chairman and General Manager of the wholly-owned subsidiary, Lanxin Technology. This dismissal is for the needs of the company's operations and management, to ensure the normative operation of the board of directors and management, and will not affect the company's production and operation. Zhao Jianzhou holds 43.4865 million shares of the company, and after being dismissed from the position of Deputy General Manager, he will strictly comply with the relevant laws and regulations regarding his shareholding.